MAD2L1 and ovarian serous adenocarcinoma: OVCAR-3 cells due to their TLR4 positivity and as a representative model of serous ovarian cancer were subsequently transfected with siRNA targeting TLR4 or MAD2 and then TLR4, MAD2 and MyD88 expression levels were assessed.